Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS-methylphenidate versus placebo crossover trial with Continuous Performance Test assessment in adults with ADHD
NL-OMON31400Recruiting
- Sponsor
- Parnassia Therapeutics
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Parnassia Therapeutics. Started Oct 2007; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON31400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31400.